Development of effective vaccines against pandemic influenza

被引：115

作者：

Subbarao, K ^{[1
]}

Murphy, BR ^{[1
]}

Fauci, AS ^{[1
]}

机构：

[1] NIAID, NIH, Bethesda, MD 20892 USA

来源：

IMMUNITY | 2006年 / 24卷 / 01期

关键词：

D O I：

10.1016/j.immuni.2005.12.005

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A key strategy to protect humans against an influenza pandemic is the development of an effective vaccine. However, the development of effective pandemic vaccines poses both practical and immunological challenges.

引用

页码：5 / 9

页数：5

共 17 条

[1] Transmission of equine influenza virus to dogs [J].

Crawford, PC ;

Dubovi, EJ ;

Castleman, WL ;

Stephenson, I ;

Gibbs, EPJ ;

Chen, L ;

Smith, C ;

Hill, RC ;

Ferro, P ;

Pompey, J ;

Bright, RA ;

Medina, MJ ;

Johnson, CM ;

Olsen, CW ;

Cox, NJ ;

Klimov, AI ;

Katz, JM ;

Donis, RO .

SCIENCE, 2005, 310 (5747) :482-485

[2] Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection [J].

de Jong, MD ;

Thanh, TT ;

Khanh, TH ;

Hien, VM ;

Smith, GJD ;

Chau, NV ;

Cam, BV ;

Qui, PT ;

Ha, DQ ;

Guan, Y ;

Peiris, JSM ;

Hien, TT ;

Farrar, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) :2667-2672

[3] Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: An experiment of nature [J].

Epstein, SL .

JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (01) :49-53

[4] Long term trends in the evolution of H(3) HA1 human influenza type A [J].

Fitch, WM ;

Bush, RM ;

Bender, CA ;

Cox, NJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :7712-7718

[5] Pandemic preparedness:: lessons learnt from H2N2 and H9N2 candidate vaccines [J].

Hehme, N ;

Engelmann, H ;

Künzel, W ;

Neumeier, E ;

Sänger, R .

MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2002, 191 (3-4) :203-208

[6] Avian flu - Isolation of drug-resistant H5N1 virus [J].

Le, QM ;

Kiso, M ;

Someya, K ;

Sakai, YT ;

Nguyen, TH ;

Nguyen, KHL ;

Pham, ND ;

Ngyen, HH ;

Yamada, S ;

Muramoto, Y ;

Horimoto, T ;

Takada, A ;

Goto, H ;

Suzuki, T ;

Suzuki, Y ;

Kawaoka, Y .

NATURE, 2005, 437 (7062) :1108-1108

[7] Vaccines for pandemic influenza [J].

Luke, CJ ;

Subbarao, K .

EMERGING INFECTIOUS DISEASES, 2006, 12 (01) :66-72

[8]

Murphy BR, 2001, FIELDS VIROLOGY, P435

[9] A universal influenza A vaccine based on the extracellular domain of the M2 protein [J].

Neirynck, S ;

Deroo, T ;

Saelens, X ;

Vanlandschoot, P ;

Jou, WM ;

Fiers, W .

NATURE MEDICINE, 1999, 5 (10) :1157-1163

[10] Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza [J].

Nicholson, KG ;

Colegate, AE ;

Podda, A ;

Stephenson, I ;

Wood, J ;

Ypma, E ;

Zambon, MC .

LANCET, 2001, 357 (9272) :1937-1943

← 1 2 →